The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127527411 12752741 1 I 20160901 20160916 20160916 EXP FR-CIPLA LTD.-2016FR18128 CIPLA GARCIA M, LE MOAL G, GODET C, BERAUD G, CHAGNEAU-DERRODE C, ROBLOT F. FIRST CASE REPORT OF RENAL IMPROVEMENT ON TENOFOVIR ALAFENAMIDE IN AN HIV/HEPATITIS B VIRUS-COINFECTED PATIENT WITH ADEFOVIR-INDUCED FANCONI^S SYNDROME. AIDS. 2016;30:1487 TO 1493 0.00 Y 0.00000 20160916 OT FR FR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127527411 12752741 1 PS Tenofovir TENOFOVIR 1 Unknown UNK Y U 78800
127527411 12752741 2 SS Tenofovir TENOFOVIR 1 Y U 78800
127527411 12752741 3 SS RITONAVIR. RITONAVIR 1 Unknown UNK Y U 0
127527411 12752741 4 SS RITONAVIR. RITONAVIR 1 Y U 0
127527411 12752741 5 SS LAMIVUDINE. LAMIVUDINE 1 Unknown UNK U U 0
127527411 12752741 6 SS LAMIVUDINE. LAMIVUDINE 1 U U 0
127527411 12752741 7 SS Darunavir DARUNAVIR 1 Unknown UNK Y U 0
127527411 12752741 8 SS Darunavir DARUNAVIR 1 Y U 0
127527411 12752741 9 SS ENTECAVIR. ENTECAVIR 1 Unknown UNK U U 0
127527411 12752741 10 SS ENTECAVIR. ENTECAVIR 1 U U 0
127527411 12752741 11 SS Atazanavir ATAZANAVIR 1 Unknown UNK Y U 0
127527411 12752741 12 SS Atazanavir ATAZANAVIR 1 Y U 0
127527411 12752741 13 SS ADEFOVIR DIPIVOXIL. ADEFOVIR DIPIVOXIL 1 Unknown 10 MG, PER DAY Y U 0 10 MG
127527411 12752741 14 SS ADEFOVIR DIPIVOXIL. ADEFOVIR DIPIVOXIL 1 Y U 0
127527411 12752741 15 SS Etravirine ETRAVIRINE 1 Unknown UNK U U 0
127527411 12752741 16 SS Etravirine ETRAVIRINE 1 U U 0
127527411 12752741 17 SS NORVIR RITONAVIR 1 Unknown UNK U U 0
127527411 12752741 18 SS NORVIR RITONAVIR 1 U U 0
127527411 12752741 19 SS Telbivudine TELBIVUDINE 1 Unknown UNK U U 0
127527411 12752741 20 SS Telbivudine TELBIVUDINE 1 U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127527411 12752741 1 HIV infection
127527411 12752741 2 Hepatitis B
127527411 12752741 3 HIV infection
127527411 12752741 4 Hepatitis B
127527411 12752741 5 HIV infection
127527411 12752741 6 Hepatitis B
127527411 12752741 7 HIV infection
127527411 12752741 8 Hepatitis B
127527411 12752741 9 HIV infection
127527411 12752741 10 Hepatitis B
127527411 12752741 11 HIV infection
127527411 12752741 12 Hepatitis B
127527411 12752741 13 HIV infection
127527411 12752741 14 Hepatitis B
127527411 12752741 15 HIV infection
127527411 12752741 16 Hepatitis B
127527411 12752741 17 HIV infection
127527411 12752741 18 Hepatitis B
127527411 12752741 19 HIV infection
127527411 12752741 20 Hepatitis B

Outcome of event

Event ID CASEID OUTC COD
127527411 12752741 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127527411 12752741 Drug resistance
127527411 12752741 Fanconi syndrome
127527411 12752741 Osteonecrosis
127527411 12752741 Osteoporosis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found